In vitro Biological Effects of Sulforaphane (SFN), Epigallocatechin-3-gallate (EGCG), and Curcumin on Breast Cancer Cells: A Systematic Review of the Literature

References

• Hirst M and Marra MA: Epigenetics and human disease. Int J Biochem Cell Biol 41, 136–146, 2009. doi: 10.1016/j.biocel.2008.09.011
   PubMed Web of Science ®Google Scholar
• Stefanska B, Karlic H, Varga F, Fabianowska-Majewska K, and Haslberger A: Epigenetic mechanisms in anti-cancer actions of bioactive food components–the implications in cancer prevention. Br J Pharmacol 167, 279–297, 2012. doi: 10.1111/j.1476-5381.2012.02002.x
   PubMed Web of Science ®Google Scholar
• Jaenisch R and Bird A: Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33 Suppl, 245–254, 2003. doi: 10.1038/ng1089
   Web of Science ®Google Scholar
• Meeran SM, Patel SN, and Tollefsbol TO: Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines. PLoS One 5, e11457, 2010. doi: 10.1371/journal.pone.0011457
   PubMed Web of Science ®Google Scholar
• Higdon JV, Delage B, Williams DE, and Dashwood RH: Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis. Pharmacol Res 55, 224–236, 2007. doi: 10.1016/j.phrs.2007.01.009
   PubMed Web of Science ®Google Scholar
• Fang MZ, Wang Y, Ai N, Hou Z, Sun Y, et al.: Tea polyphenol (−)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res 63, 7563–7570, 2003.
   PubMed Web of Science ®Google Scholar
• Lee WJ and Zhu BT: Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols. Carcinogenesis 27, 269–277, 2006. doi: 10.1093/carcin/bgi206
   PubMed Web of Science ®Google Scholar
• Shehzad A, Ul Islam S, Lee J, and Lee YS: Prostaglandin E2 reverses curcumin-induced inhibition of survival signal pathways in human colorectal carcinoma (HCT-15) cell lines. Mol Cells 37, 899–906, 2014. doi: 10.14348/molcells.2014.0212
   PubMed Web of Science ®Google Scholar
• Moghadamtousi SZ, Kadir HA, Hassandarvish P, Tajik H, Abubakar S, et al.: A review on antibacterial, antiviral, and antifungal activity of curcumin. Biomed Res Int 2014, 186864, 2014. doi: 10.1155/2014/186864
   PubMed Web of Science ®Google Scholar
• Aggarwal BB and Shishodia S: Suppression of the nuclear factor-kappaB activation pathway by spice-derived phytochemicals: reasoning for seasoning. Ann N Y Acad Sci 1030, 434–441, 2004. doi: 10.1196/annals.1329.054
   PubMed Web of Science ®Google Scholar
• Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, et al.: Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4, 1, 2015. doi: 10.1186/2046-4053-4-1
   PubMed Web of Science ®Google Scholar
• Tao Y, Liu S, Briones V, Geiman TM, and Muegge K: Treatment of breast cancer cells with DNA demethylating agents leads to a release of Pol II stalling at genes with DNA-hypermethylated regions upstream of TSS. Nucleic Acids Res 39, 9508–9520, 2011. doi: 10.1093/nar/gkr611
   PubMed Web of Science ®Google Scholar
• Terzi YK, Özer Kaya Ö, Darcansoy İşeri Ö, Çelik Z, and Şahin Fİ: Epigallocatechin 3-gallate applications on HT-29 and MCF-7 cell lines and evaluation of tumor suppressor gene methylation. Turk J Biol 39, 698–704, 2015. doi: 10.3906/biy-1412-82
   Web of Science ®Google Scholar
• Rath SK, Deb M, Sengupta D, Kari V, Kar S, et al.: Silencing of ZRF1 impedes survival of estrogen receptor positive MCF-7 cells and potentiates the effect of curcumin. Tumour Biol 37(9), 12535–12546, 2016. doi: 10.1007/s13277-016-5114-y
   PubMed Web of Science ®Google Scholar
• Gurung RL, Lim SN, Low GKM, and Hande MP: MST-312 alters telomere dynamics, gene expression profiles and growth in human breast cancer cells. J Nutrigenet Nutrigenomics 7, 283–298, 2014. doi: 10.1159/000381346
   PubMed Web of Science ®Google Scholar
• Deb G, Thakur VS, Limaye AM, and Gupta S: Epigenetic induction of tissue inhibitor of matrix metalloproteinase-3 by green tea polyphenols in breast cancer cells. Mol Carcinog 54, 485–499, 2015. doi: 10.1002/mc.22121
   PubMed Web of Science ®Google Scholar
• Meeran SM, Patel SN, Li Y, Shukla S, and Tollefsbol TO: Bioactive dietary supplements reactivate ER expression in ER-negative breast cancer cells by active chromatin modifications. PLoS One 7, e37748, 2012. doi: 10.1371/journal.pone.0037748
   PubMed Web of Science ®Google Scholar
• Li Y, Yuan YY, Meeran SM, and Tollefsbol TO: Synergistic epigenetic reactivation of estrogen receptor-alpha (ERalpha) by combined green tea polyphenol and histone deacetylase inhibitor in ERalpha-negative breast cancer cells. Mol Cancer 9, 274, 2010. doi: 10.1186/1476-4598-9-274
   PubMed Web of Science ®Google Scholar
• Liu Y, Chakravarty S, and Dey M: Phenethylisothiocyanate alters site- and promoter-specific histone tail modifications in cancer cells. PLoS One 8, e64535, 2013. doi: 10.1371/journal.pone.0064535
   PubMed Web of Science ®Google Scholar
• Medina-Aguilar R, Perez-Plasencia C, Marchat LA, Gariglio P, Garcia Mena J, et al.: Methylation landscape of human breast cancer cells in response to dietary compound resveratrol. PLoS One 11, e0157866, 2016. doi: 10.1371/journal.pone.0157866
   PubMed Web of Science ®Google Scholar
• Yarla NS, Bishayee A, Sethi G, Reddanna P, Kalle AM, et al.: Targeting arachidonic acid pathway by natural products for cancer prevention and therapy. Semin Cancer Biol 40–41, 48–81, 2016. doi: 10.1016/j.semcancer.2016.02.001
   PubMed Web of Science ®Google Scholar
• Katsori AM, Palagani A, Bougarne N, Hadjipavlou-Litina D, Haegeman G, et al.: Inhibition of the NF-kappaB signaling pathway by a novel heterocyclic curcumin analogue. Molecules 20, 863–878, 2015. doi: 10.3390/molecules20010863
   PubMed Web of Science ®Google Scholar
• Bolhassani A: Cancer chemoprevention by natural carotenoids as an efficient strategy. Anticancer Agents Med Chem 15, 1026–1031, 2015.
   PubMed Web of Science ®Google Scholar
• Chen H, Gao S, Li J, Liu D, Sheng C, et al.: Wedelolactone disrupts the interaction of EZH2-EED complex and inhibits PRC2-dependent cancer. Oncotarget 6, 13049–13059, 2015.
   PubMed Web of Science ®Google Scholar
• Degner SC, Papoutsis AJ, Selmin O, and Romagnolo DF: Targeting of aryl hydrocarbon receptor-mediated activation of cyclooxygenase-2 expression by the indole-3-carbinol metabolite 3,3 -diindolylmethane in breast cancer cells 1,2. J Nutr 139, 26–32, 2009. doi: 10.3945/jn.108.099259
   PubMed Web of Science ®Google Scholar
• Ivanov M, Kacevska M, and Ingelman-Sundberg M: Epigenomics and interindividual differences in drug response. Clin Pharmacol Ther 92, 727–736, 2012. doi: 10.1038/clpt.2012.152
   PubMed Web of Science ®Google Scholar
• Kala R and Tollefsbol TO: A novel combinatorial epigenetic therapy using resveratrol and pterostilbene for restoring estrogen receptor-α (ERα) expression in ERα-negative breast cancer cells. PLoS ONE 11, 1–17, 2016. doi: 10.1371/journal.pone.0155057
   Web of Science ®Google Scholar
• Kuck D, Singh N, Lyko F, and Medina-Franco JL: Novel and selective DNA methyltransferase inhibitors: Docking-based virtual screening and experimental evaluation. Bioorg Med Chem 18, 822–829, 2010. doi: 10.1016/j.bmc.2009.11.050
   PubMed Web of Science ®Google Scholar
• Liu AG and Erdman JW: Lycopene and apo-10′-lycopenal do not alter DNA methylation of GSTP1 in LNCaP cells. Biochem Biophys Res Commun 412, 479–482, 2011. doi: 10.1016/j.bbrc.2011.07.124
   PubMed Web of Science ®Google Scholar
• Lubecka-Pietruszewska K, Kaufman-Szymczyk A, Stefanska B, and Fabianowska-Majewska K: Folic acid enforces DNA methylation-mediated transcriptional silencing of PTEN, APC and RARbeta2 tumour suppressor genes in breast cancer. Biochem Biophys Res Commun 430, 623–628, 2013. doi: 10.1016/j.bbrc.2012.11.103
   PubMed Web of Science ®Google Scholar
• Mohammadi R, Yousefi R, Aseman MD, Nabavizadeh SM, and Rashidi M: DNA binding and anticancer activity of novel cyclometalated platinum (II) complexes. Anticancer Agents Med Chem 15, 107–114, 2015.
   PubMed Web of Science ®Google Scholar
• Zhang Y and Chen H: Genistein, an epigenome modifier during cancer prevention. Epigenetics 6, 888–891, 2011. doi: 10.4161/epi.6.7.16315
   PubMed Web of Science ®Google Scholar
• Lubecka K, Kurzava L, Flower K, Buvala H, Zhang H, et al.. Stilbenoids remodel the DNA methylation patterns in breast cancer cells and inhibit oncogenic NOTCH signaling through epigenetic regulation of MAML2 transcriptional activity. Carcinogenesis 37(7), 656–68, 2016. doi: 10.1093/carcin/bgw048
   PubMed Web of Science ®Google Scholar
• Li Q, Yao Y, Eades G, Liu Z, Zhang Y, et al.: Downregulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancer. Oncogene 33, 2589–2600, 2014. doi: 10.1038/onc.2013.226
   PubMed Web of Science ®Google Scholar
• Berner C, Aumuller E, Gnauck A, Nestelberger M, Just A, et al.: Epigenetic control of estrogen receptor expression and tumor suppressor genes is modulated by bioactive food compounds. Ann Nutr Metab 57, 183–189, 2010. doi: 10.1159/000321514
   PubMed Web of Science ®Google Scholar
• Blancafort A, Giro-Perafita A, Oliveras G, Palomeras S, Turrado C, et al.: Dual fatty acid synthase and HER2 signaling blockade shows marked antitumor activity against breast cancer models resistant to anti-HER2 drugs. PLoS One 10, e0131241, 2015. doi: 10.1371/journal.pone.0131241
   PubMed Web of Science ®Google Scholar
• Chew YC, Adhikary G, Wilson GM, Xu W, and Eckert RL: Sulforaphane induction of p21Cip1 cyclin-dependent kinase inhibitor expression requires p53 and Sp1 transcription factors and Is p53-dependent. J Biol Chem 287, 16168–16178, 2012. doi: 10.1074/jbc.M111.305292
   PubMed Web of Science ®Google Scholar
• Sinha S, Shukla S, Khan S, Tollefsbol TO, and Meeran SM: Epigenetic reactivation of p21CIP1/WAF1 and KLOTHO by a combination of bioactive dietary supplements is partially ERalpha-dependent in ERalpha-negative human breast cancer cells. Mol Cell Endocrinol 406, 102–114, 2015. doi: 10.1016/j.mce.2015.02.020
   PubMed Web of Science ®Google Scholar
• Lubecka-Pietruszewska K, Kaufman-Szymczyk A, Stefanska B, Cebula-Obrzut B, Smolewski P, et al.: Sulforaphane alone and in combination with clofarabine epigenetically regulates the expression of DNA methylation-silenced tumour suppressor genes in human breast cancer cells. J Nutrigenet Nutrigenomics 8, 91–101, 2015. doi: 10.1159/000439111
   PubMed Web of Science ®Google Scholar
• Deb M, Sengupta D, Kar S, Rath SK, Parbin S, et al.: Elucidation of caveolin 1 both as a tumor suppressor and metastasis promoter in light of epigenetic modulators. Tumour Biol 35, 12031–12047, 2014. doi: 10.1007/s13277-014-2502-z
   PubMed Web of Science ®Google Scholar
• Rao X, Evans J, Chae H, Pilrose J, Kim S, et al.: CpG island shore methylation regulates caveolin-1 expression in breast cancer. Oncogene 32, 4519–4528, 2013. doi: 10.1038/onc.2012.474
   PubMed Web of Science ®Google Scholar
• Huang C, Qiu Z, Wang L, Peng Z, Jia Z, et al.: A novel FoxM1-caveolin signaling pathway promotes pancreatic cancer invasion and metastasis. Cancer Res 72, 655–665, 2012. doi: 10.1158/0008-5472.CAN-11-3102
   PubMed Web of Science ®Google Scholar
• Mirza S, Sharma G, Parshad R, Gupta SD, Pandya P, et al.: Expression of DNA methyltransferases in breast cancer patients and to analyze the effect of natural compounds on DNA methyltransferases and associated proteins. J Breast Cancer 16, 23–31, 2013. doi: 10.4048/jbc.2013.16.1.23
   PubMed Web of Science ®Google Scholar
• Conway KE, McConnell BB, Bowring CE, Donald CD, Warren ST, et al.: TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers. Cancer Res 60, 6236–6242, 2000.
   PubMed Web of Science ®Google Scholar
• Meeran SM, Patel SN, Chan TH, and Tollefsbol TO: A novel prodrug of epigallocatechin-3-gallate: differential epigenetic hTERT repression in human breast cancer cells. Cancer Prev Res (Phila) 4, 1243–1254, 2011. doi: 10.1158/1940-6207.capr-11-0009
   PubMed Web of Science ®Google Scholar
• Berletch JB, Liu C, Love WK, Andrews LG, Katiyar SK, et al.: Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG. J Cell Biochem 103, 509–519, 2008. doi: 10.1002/jcb.21417
   PubMed Web of Science ®Google Scholar
• Tyagi T, Treas JN, Mahalingaiah PK, and Singh KP: Potentiation of growth inhibition and epigenetic modulation by combination of green tea polyphenol and 5-aza-2′-deoxycytidine in human breast cancer cells. Breast Cancer Res Treat 149, 655–668, 2015. doi: 10.1007/s10549-015-3295-5
   PubMed Web of Science ®Google Scholar
• Weng JR, Lai IL, Yang HC, Lin CN, and Bai LY: Identification of kazinol Q, a natural product from Formosan plants, as an inhibitor of DNA methyltransferase. Phytother Res 28, 49–54, 2014. doi: 10.1002/ptr.4955
   PubMed Web of Science ®Google Scholar
• Sutapa M, Ruma S, Jaydip B, and Madhumita R: Curcumin inhibits histone deacetylase leading to cell cycle arrest and apoptosis via upregulation of p21 in breast cancer cell lines. Int J Green Nanotechnol 4, 183–197, 2012.
   Google Scholar
• Collins HM, Abdelghany MK, Messmer M, Yue B, Deeves SE, et al.: Differential effects of garcinol and curcumin on histone and p53 modifications in tumour cells. BMC Cancer 13, 37, 2013. doi: 10.1186/1471-2407-13-37
   PubMed Web of Science ®Google Scholar
• Jiang M, Huang O, Zhang X, Xie Z, Shen A, et al.: Curcumin induces cell death and restores tamoxifen sensitivity in the antiestrogen-resistant breast cancer cell lines MCF-7/LCC2 and MCF-7/LCC9. Molecules 18, 701–720, 2013. doi:10.3390/molecules18010701
   PubMed Web of Science ®Google Scholar
• Moiseeva EP, Almeida GM, Jones GD, and Manson MM: Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells. Mol Cancer Ther 6, 3071–3079, 2007. doi: 10.1158/1535-7163.mct-07-0117
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Sarkar R, Biswas J, and Roy M: Curcumin inhibits histone deacetylase leading to cell cycle arrest and apoptosis via upregulation of p21 in breast cancer cell lines. Int J Green Nanotechnol Biomed 4, 183–197, 2012. doi: 10.1080/19430892.2012.691799
   Google Scholar
• Stuart EC, Jarvis RM, and Rosengren RJ: In vitro mechanism of action for the cytotoxicity elicited by the combination of epigallocatechin gallate and raloxifene in MDA-MB-231 cells. Oncol Rep 24, 779–785, 2010.
   PubMed Web of Science ®Google Scholar
• Kavanagh KT, Hafer LJ, Kim DW, Mann KK, Sherr DH, et al.: Green tea extracts decrease carcinogen-induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture. J Cell Biochem 82, 387–398, 2001.
   PubMed Web of Science ®Google Scholar
• Sen T, Dutta A, and Chatterjee A: Epigallocatechin-3-gallate (EGCG) downregulates gelatinase-B (MMP-9) by involvement of FAK/ERK/NFkappaB and AP-1 in the human breast cancer cell line MDA-MB-231. Anticancer Drugs 21, 632–644, 2010.
   PubMed Web of Science ®Google Scholar
• Gurung RL, Lim SN, Low GK, and Hande MP: MST-312 alters telomere dynamics, gene expression profiles and growth in human breast cancer cells. J Nutrigenet Nutrigenomics 7, 283–298, 2014. doi: 10.1159/000381346
   PubMed Web of Science ®Google Scholar
• Aloia L, Demajo S, and Di Croce L: ZRF1: a novel epigenetic regulator of stem cell identity and cancer. Cell Cycle 14, 510–515, 2015. doi: 10.4161/15384101.2014.988022
   PubMed Web of Science ®Google Scholar